Warts - Moles - Skin Tags

Manufacturer: Newton Laboratories, Inc.
Effective date: 2011-03-01
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-06-01 02:05:02

Label at a glance#

ProductWarts - Moles - Skin Tags

Active ingredientAntimony Trisulfide, Bryonia Alba Root, Oyster Shell Calcium Carbonate, Crude, Causticum, Solanum Dulcamara Top, Graphite, Lycopodium Clavatum Spore, Mercuric Sulfide, Sodium Carbonate, Nitric Acid, Strychnos Nux-vomica Seed, Toxicodendron Pubescens Leaf, Juniperus Sabina Leafy Twig, Sepia Officinalis Juice, Silicon Dioxide, Delphinium Staphisagria Seed, Sulfur, Thuja Occidentalis Leafy Twig, Taraxacum Officinale

Label structure10 sections

Contacts and useful links#

PhoneLabel contact1.800.448.7256

Websitewww.newtonlabs.net

www.newtonlabs.net

Label contents#

Full prescribing information#

INDICATIONS & USAGE SECTION

Warts - Moles - Skin Tags Formulated for various types of skin conditions such as warts (including genital), moles, keloids, molluscum and skin tags.

DOSAGE & ADMINISTRATION SECTION

Directions: Ages 12 and up, take 6 pellets orally (ages 0 to 11, give 3 pellets) one to four times daily or as directed by a healthcare professional. Under age 2, crush or dissolve pellets in purified water. Sensitive persons begin with 1 pellet and gradually increase to full dose.

OTC - ACTIVE INGREDIENT SECTION

Antimon. crud. 15x, Bryonia 15x, Calc.carb. 15x, Causticum 15x, Dulcamara 15x, Graphites 15x, Lycopodium 15x, Merc. sulph. rub. 15x, Nat. carb. 15x, Nitricum ac.15x, Nux vom. 15x, Rhus toxicodendron 15x, Sabina 15x, Sepia 15x, Silicea 15x, Staphysag. 15x, Sulphur 15x, Thuja occ. 15x, Taraxacum 3x, Thuja occ. 3x.

OTC - PURPOSE SECTION

Formulated for various types of skin conditions such as warts (including genital), moles, keloids, molluscum and skin tags.

INACTIVE INGREDIENT SECTION

Inactive Ingredients: Gluten-free, non-GMO, beet-derived sucrose pellets.

QUESTIONS SECTION

OTC - QUESTIONS SECTION

www.newtonlabs.net Newton Laboratories, Inc. FDA Est # 1051203 - Conyers, GA 30012
Questions? 1.800.448.7256

WARNINGS SECTION

Warning: Do not use if tamper - evident seal is broken or missing. Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days. Keep out of reach of children.

OTC - PREGNANCY OR BREAST FEEDING SECTION

Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

PACKAGE LABEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
55714-2271-0	2020-01-31	C162847	48780-1	9d75b9d0-5746-f424-e053-dadaa90a57ce	Warts - Moles - Skin Tags
55714-2271-1	2020-01-31	C162847	48780-1	9d75b9d0-5746-f424-e053-dadaa90a57ce	Warts - Moles - Skin Tags
55714-2271-2	2020-01-31	C162847	48780-1	9d75b9d0-5746-f424-e053-dadaa90a57ce	Warts - Moles - Skin Tags

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
55714-2271-0	Warts - Moles - Skin Tags	7.08 g in 1 BOTTLE, GLASS	PELLET	7.08	1
55714-2271-1	Warts - Moles - Skin Tags	28.35 g in 1 BOTTLE, GLASS	PELLET	28.35	1
55714-2271-2	Warts - Moles - Skin Tags	56.7 g in 1 BOTTLE, GLASS	PELLET	56.7	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
55714-2271	WARTS - MOLES - SKIN TAGS (ANTIMON. CRUD., BRYONIA, CALC.CARB., CAUSTICUM, DULCAMARA, GRAPHITES, LYCOPODIUM, MERC. SULPH. RUB., NAT. CARB., NITRICUM AC., NUX VOM., RHUS TOXICODENDRON, SABINA, SEPIA, SILICEA, STAPHYSAG., SULPHUR, THUJA OCC., TARAXACUM) PELLET [NEWTON LABORATORIES, INC.]	1	Legacy NDC, 3 package rows	20131016_8b8d6933-1c3b-fc4f-ab58-454eba84c0f0.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Antimony Trisulfide	ACTIVE INGREDIENT	F79059A38U	1
Bryonia Alba Root	ACTIVE INGREDIENT	T7J046YI2B	1
Causticum	ACTIVE INGREDIENT	DD5FO1WKFU	1
Delphinium Staphisagria Seed	ACTIVE INGREDIENT	00543AP1JV	1
Graphite	ACTIVE INGREDIENT	4QQN74LH4O	1
Juniperus Sabina Leafy Twig	ACTIVE INGREDIENT	Z5BEX9K2G1	1
Lycopodium Clavatum Spore	ACTIVE INGREDIENT	C88X29Y479	1
Mercuric Sulfide	ACTIVE INGREDIENT	ZI0T668SF1	1
Nitric Acid	ACTIVE INGREDIENT	411VRN1TV4	1
Oyster Shell Calcium Carbonate, Crude	ACTIVE INGREDIENT	2E32821G6I	1
Sepia Officinalis Juice	ACTIVE INGREDIENT	QDL83WN8C2	1
Silicon Dioxide	ACTIVE INGREDIENT	ETJ7Z6XBU4	1
Sodium Carbonate	ACTIVE INGREDIENT	45P3261C7T	1
Solanum Dulcamara Top	ACTIVE INGREDIENT	KPS1B1162N	1
Strychnos Nux-vomica Seed	ACTIVE INGREDIENT	269XH13919	1
Sulfur	ACTIVE INGREDIENT	70FD1KFU70	1
Taraxacum Officinale	ACTIVE INGREDIENT	39981FM375	1
Thuja Occidentalis Leafy Twig	ACTIVE INGREDIENT	1NT28V9397	1
Toxicodendron Pubescens Leaf	ACTIVE INGREDIENT	6IO182RP7A	1
Antimony Trisulfide	ACTIVE MOIETY	F79059A38U	1
Bryonia Alba Root	ACTIVE MOIETY	T7J046YI2B	1
Carbonate Ion	ACTIVE MOIETY	7UJQ5OPE7D	1
Causticum	ACTIVE MOIETY	DD5FO1WKFU	1
Delphinium Staphisagria Seed	ACTIVE MOIETY	00543AP1JV	1
Graphite	ACTIVE MOIETY	4QQN74LH4O	1
Juniperus Sabina Leafy Twig	ACTIVE MOIETY	Z5BEX9K2G1	1
Lycopodium Clavatum Spore	ACTIVE MOIETY	C88X29Y479	1
Mercuric Cation	ACTIVE MOIETY	ED30FJ8Y42	1
Nitric Acid	ACTIVE MOIETY	411VRN1TV4	1
Oyster Shell Calcium Carbonate, Crude	ACTIVE MOIETY	2E32821G6I	1
Sepia Officinalis Juice	ACTIVE MOIETY	QDL83WN8C2	1
Silicon Dioxide	ACTIVE MOIETY	ETJ7Z6XBU4	1
Solanum Dulcamara Top	ACTIVE MOIETY	KPS1B1162N	1
Strychnos Nux-vomica Seed	ACTIVE MOIETY	269XH13919	1
Sulfur	ACTIVE MOIETY	70FD1KFU70	1
Taraxacum Officinale	ACTIVE MOIETY	39981FM375	1
Thuja Occidentalis Leafy Twig	ACTIVE MOIETY	1NT28V9397	1
Toxicodendron Pubescens Leaf	ACTIVE MOIETY	6IO182RP7A	1
Sucrose	INACTIVE INGREDIENT	C151H8M554	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 24 matching rows.

Warts - Moles - Skin Tags
Antimon. crud., Bryonia, Calc.carb., Causticum, Dulcamara, Graphites, Lycopodium, Merc. sulph. rub., Nat. carb., Nitricum ac., Nux vom., Rhus toxicodendron, Sabina, Sepia, Silicea, Staphysag., Sulphur, Thuja occ., Taraxacum
Antimony Trisulfide
Bryonia Alba Root
Oyster Shell Calcium Carbonate, Crude
Causticum
Solanum Dulcamara Top
Graphite
Lycopodium Clavatum Spore
Mercuric Sulfide
Mercuric Cation
Sodium Carbonate
Carbonate Ion
Nitric Acid
Strychnos Nux-vomica Seed
Toxicodendron Pubescens Leaf
Juniperus Sabina Leafy Twig
Sepia Officinalis Juice
Silicon Dioxide
Delphinium Staphisagria Seed
Sulfur
Thuja Occidentalis Leafy Twig
Taraxacum Officinale
Sucrose

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
55714-2271	55714-2271-1, 55714-2271-2, 55714-2271-0

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 20 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
Antimony Trisulfide	F79059A38U	ACTIB
Bryonia Alba Root	T7J046YI2B	ACTIB
Oyster Shell Calcium Carbonate, Crude	2E32821G6I	ACTIB
Causticum	DD5FO1WKFU	ACTIB
Solanum Dulcamara Top	KPS1B1162N	ACTIB
Graphite	4QQN74LH4O	ACTIB
Lycopodium Clavatum Spore	C88X29Y479	ACTIB
Mercuric Sulfide	ZI0T668SF1	ACTIB
Sodium Carbonate	45P3261C7T	ACTIB
Nitric Acid	411VRN1TV4	ACTIB
Strychnos Nux-vomica Seed	269XH13919	ACTIB
Toxicodendron Pubescens Leaf	6IO182RP7A	ACTIB
Juniperus Sabina Leafy Twig	Z5BEX9K2G1	ACTIB
Sepia Officinalis Juice	QDL83WN8C2	ACTIB
Silicon Dioxide	ETJ7Z6XBU4	ACTIB
Delphinium Staphisagria Seed	00543AP1JV	ACTIB
Sulfur	70FD1KFU70	ACTIB
Thuja Occidentalis Leafy Twig	1NT28V9397	ACTIB
Taraxacum Officinale	39981FM375	ACTIB
Sucrose	C151H8M554	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 48 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
Sucrose	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTABLE, LIPOSOMAL / INTRAVENOUS		7560 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		2000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION / SUBCUTANEOUS	47.75 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUPPOSITORY / RECTAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS		308 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TROCHE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET / SUBLINGUAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS		1 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, EMULSION / INTRAVENOUS		970 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SOLUTION / RECTAL	35.42 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS	9.4 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS	900 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET / BUCCAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	LOZENGE / TRANSMUCOSAL		1255 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION / INTRAVENOUS		1950 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	LOZENGE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii candidate 48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
093c4b61-749c-f7a8-2b52-ad59e88711c6			8b8d6933-1c3b-fc4f-ab58-454eba84c0f0	2011-03-01	Warnings	Exact identifier spl id: 093c4b61-749c-f7a8-2b52-ad59e88711c6 spl set id: 8b8d6933-1c3b-fc4f-ab58-454eba84c0f0

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.